Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Journal of Clinical Pharmacology|October 13, 2025
Anthropometric Exclusions in Pediatric Clinical Trials: Implications for Medication Dosing in Malnourished ChildrenSusan M Abdel-Rahman, Sherbet Samuels, Janie Cole, et al.
Therapeutic Innovation & Regulatory Science|October 4, 2025
A Review of Trials for Unsuccessful Pediatric Drug Development Programs Submitted to the US Food and Drug Administration 2015-2022Sherbet Samuels, Mark Seaton, Susan M Abdel-Rahman, et al.
Journal of Clinical Pharmacology|November 9, 2023
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer AgentsWilliam C Zamboni, Rosane Charlab, Gilbert J Burckart, et al.
Journal of Clinical Pharmacology|July 9, 2013
Evaluation of hepatic impairment dosing recommendations in FDA-approved product labelsYang Chang, Gilbert J Burckart, Lawrence J Lesko, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United StatesYun-Kyoung Song, Nayoung Han, Gilbert J Burckart, et al.
Clinical Pharmacology and Therapeutics|July 9, 2023
Assessing Information Gaps Associated with Initial Pediatric Study Plans for New Oncology Drug and Biological ProductsDaphne Guinn, Marilyn Gafford, Gilbert J Burckart, et al.
Pharmacotherapy|July 27, 2010
Evaluation of renal drug dosing: prescribing information and clinical pharmacist approachesThomas C Dowling, Gary R Matzke, John E Murphy, et al.
Transplant Immunology|January 24, 2009
A novel method for monitoring glucocorticoid-induced changes of the glucocorticoid receptor in kidney transplant recipientsYan Chen, Gilbert J Burckart, Tariq Shah, et al.
Journal of Clinical Pharmacology|September 25, 2021
Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020Kyunghun Park, Kristina Vishnevetskaya, Jayabharathi Vaidyanathan, et al.
Journal of Clinical Pharmacology|November 9, 2023
Inclusion of Subjects who are Obese in Drug Development: Current Status and OpportunitiesJayabharathi Vaidyanathan, Elimika Pfuma Fletcher, Anuradha Ramamoorthy, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Pharmacology|October 13, 2025
Anthropometric Exclusions in Pediatric Clinical Trials: Implications for Medication Dosing in Malnourished ChildrenSusan M Abdel-Rahman, Sherbet Samuels, Janie Cole, et al.
Therapeutic Innovation & Regulatory Science|October 4, 2025
A Review of Trials for Unsuccessful Pediatric Drug Development Programs Submitted to the US Food and Drug Administration 2015-2022Sherbet Samuels, Mark Seaton, Susan M Abdel-Rahman, et al.
Journal of Clinical Pharmacology|November 9, 2023
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer AgentsWilliam C Zamboni, Rosane Charlab, Gilbert J Burckart, et al.
Journal of Clinical Pharmacology|July 9, 2013
Evaluation of hepatic impairment dosing recommendations in FDA-approved product labelsYang Chang, Gilbert J Burckart, Lawrence J Lesko, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United StatesYun-Kyoung Song, Nayoung Han, Gilbert J Burckart, et al.
Clinical Pharmacology and Therapeutics|July 9, 2023
Assessing Information Gaps Associated with Initial Pediatric Study Plans for New Oncology Drug and Biological ProductsDaphne Guinn, Marilyn Gafford, Gilbert J Burckart, et al.
Pharmacotherapy|July 27, 2010
Evaluation of renal drug dosing: prescribing information and clinical pharmacist approachesThomas C Dowling, Gary R Matzke, John E Murphy, et al.
Transplant Immunology|January 24, 2009
A novel method for monitoring glucocorticoid-induced changes of the glucocorticoid receptor in kidney transplant recipientsYan Chen, Gilbert J Burckart, Tariq Shah, et al.
Journal of Clinical Pharmacology|September 25, 2021
Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020Kyunghun Park, Kristina Vishnevetskaya, Jayabharathi Vaidyanathan, et al.
Journal of Clinical Pharmacology|November 9, 2023
Inclusion of Subjects who are Obese in Drug Development: Current Status and OpportunitiesJayabharathi Vaidyanathan, Elimika Pfuma Fletcher, Anuradha Ramamoorthy, et al.
Pageof 13